Learn more

SANOFI AVENTIS SA

Overview
  • Total Patents
    123
About

SANOFI AVENTIS SA has a total of 123 patent applications. Its first patent ever was published in 2004. It filed its patents most often in France and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are STOICESCU DAN, NSAB AF NEUROSEARCH SWEDEN AB and LY TAI WEI.

Patent filings in countries

World map showing SANOFI AVENTIS SAs patent filings in countries
# Country Total Patents
#1 France 122
#2 China 1

Patent filings per year

Chart showing SANOFI AVENTIS SAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Rinaldi Carmona Murielle 19
#2 Barth Francis 18
#3 Congy Christian 14
#4 Casellas Pierre 13
#5 Dubois Laurent 9
#6 Evanno Yannick 9
#7 Malanda Andre 9
#8 Bouaboula Monsif 8
#9 Fours Baptiste 8
#10 Coquerel Gerard 8

Latest patents

Publication Filing date Title
FR2925492A1 New substituted thiol compounds useful for stabilizing a semiconductor nanocrystal or a nanoparticle in aqueous medium, and in conjugate, which is useful as fluorescent probe in medical imaging or in biology
FR2930148A1 Use of dronedarone to prepare medicament to prevent mortality and/or cardiovascular hospitalizations in patients having e.g. history of atrial fibrillation/atrial flutter, cerebrovascular accident and non-rheumatic valvular heart disease
FR2928645A1 Novel carbazole derivatives inhibitors of hsp90, compositions containing same and use thereof
FR2921657A1 New nicotinamide derivatives useful for the preparation of a medicament for the treatment or prevention of cancer
FR2919869A1 Novel n, n'-2,4-dianilinopyrimidine derivatives, their preparation as medicaments, pharmaceutical compositions and in particular as inhibitors of ikk
FR2919865A1 Rimonabant dmso solvate, process for preparing the same and pharmaceutical compositions containing same
FR2919862A1 Rimonabant 3-methylbutan-1-ol solvate, process for preparing the same, and pharmaceutical compositions containing same
FR2919866A1 Rimonabant methanol solvate, process for preparing the same, and pharmaceutical compositions containing same
FR2919863A1 Rimonabant n-methylpyrrolidone solvate, process for preparing the same, and pharmaceutical compositions containing same
FR2919868A1 Rimonabant n, n-dimethyformamide solvate and process for preparing the same
FR2919861A1 Rimonabant isopranol solvate, process for preparing the same, and pharmaceutical compositions containing same
FR2919864A1 Rimonabant 1,4-dioxane solvate, process for preparing the same, and pharmaceutical compositions containing same
FR2919867A1 Rimonabant 2-methoxyethanol solvate and process for preparing the same
FR2919610A1 Tricyclic n-heteroaryl-carboxamide derivatives, their preparation and their therapeutic use
FR2919288A1 1,2,3,4-tetrahydropyrrolo [1,2-a] pyrazine-6-carboxamide derivatives, their preparation and therapeutic use thereof
FR2919286A1 New dihydroquinazoline- or dihydroisoquinoline carboxamide compounds are beta-secretase inhibitors useful to treat e.g. senile dementia, mild cognitive disorder, Huntington disease, Creutzfeldt-Jakob disease, migraine and anxiety
FR2919289A1 2,3,4,5-tetrahydropyrrolo [1,2-a] [1,4] -diazepin-7-carboxamide derivatives, their preparation and their therapeutic use.
FR2919184A1 Use of 5-(4-chlorophennyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic acid as a medicament for treating e.g. chronic pain, neuropathic pain, inflammation, benign hypertrophy of the prostate and diabetic neuropathy
FR2918986A1 6-cycloamino-3- (pyridazin-4-yl) imidazo [1,2-b] -pyridazine derivatives, their preparation and their therapeutic use
FR2917735A1 New substituted indazoles, their preparation and their therapeutic use